Evidence map›Paper›PMID 25274590›Full record

ArticleNeurosciences (Riyadh, Saudi Arabia)2014

Association between human leukocyte antigen-DR and demylinating Guillain-Barre syndrome.

Zaki N Hasan, Haider H Zalzala, Hyam R Mohammedsalih, Batool M Mahdi, Laheeb A Abid, Zena N Shakir, Maithem J Fadhel

Open access · greenAbstract read
In one paragraph

Article in Neurosciences (Riyadh, Saudi Arabia), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. A review of the role of genetic factors in Guillain-Barré syndrome.Journal of molecular neuroscience : MN · 2021
    Review
  6. Article
  7. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  8. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Overexpression of HLA-DR is associated with prognosis of glioma patients.International journal of clinical and experimental pathology · 2015
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zaki N HasanHLA Typing Research Unit, Al-Kindy College of Medicine, Baghdad University, Baghdad, Iraq.
Haider H Zalzala
Hyam R Mohammedsalih
Batool M Mahdi
Laheeb A Abid
Zena N Shakir
Maithem J Fadhel
University of Baghdad · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo find an association between human leukocyte antigen (HLA) class II DRB1, DRB3, DRB4, and DRB5 alleles frequencies in a sample of Iraqi patients with Guillain-Barre syndrome (GBS) and compare with a healthy control group.

methodsWe performed a cross-sectional study consisting of 30 Iraqi Arab patients with GBS attending the Neurological Department in the Neuroscience Hospital, Baghdad, Iraq between September 2012 and June 2013. The control group comprised 42 apparently healthy volunteers. Human leukocyte antigen genotyping for HLA DRB1, DRB3, DRB4, and DRB5 was performed using the polymerase chain reaction-sequence-specific primers method. The allele frequencies were compared across both groups. Major histocompatibility complex (MHC)-class II HLA-DR genotyping and serotyping were performed by software analysis.

resultsWe found increased frequencies of HLA genotype DRB1*03:01 (p=0.0009), DRB1*07:01 (p=0.0015), and DRB4*01:01 (p<0.0001) in patients with GBS compared with healthy controls. The HLA DR6 was increased in the control group (p<0.0001).

conclusionOur results suggest an association between HLA-DRB1*03:01, DRB1*07:01, DRB4*01:01, and HLA DR3, DR7 and a susceptibility to GBS.

Indexed as

Genes, MHC Class IIAdolescentAdultAgedAllelesArabsChildFemaleGene FrequencyGenetic Predisposition to DiseaseGuillain-Barre SyndromeHistocompatibility TestingHLA-DR AntigensHLA-DRB1 ChainsHumansIraqHLA-DR AntigensHLA-DRB1*03:01 antigenHLA-DRB1 ChainsHLA-DRB4*01:01 antigen

Identifiers

PMID25274590
PMCPMC4727669
OpenAlexW2409336731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.